🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alice Zervoudakis

Memorial Sloan Kettering Cancer Center

ORCID: 0009-0000-4818-7933

Also affiliated with Cornell University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.3Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes

Cancer(2021)10.1002/cncr.33812
Top 17%
1.2DataRank
Top 17%42 citations

Catherine O’Connor, Joanne F. Chou, Marinela Capanu, Wungki Park, Chaitanya Bandlamudi +19 more

Papers

Driven by 7 papers — median percentile 53. Top paper: “First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial”.

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30169-8
N/A
5.1DataRank · unranked
360 citations

Steven B. Maron, Walid K. Chatila, Brittanie M Millang, Shweta S. Chavan, Carly Alterman +20 more

Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes

Cancer(2021)10.1002/cncr.33812
Top 17%
1.2DataRank
Top 17%42 citations

Catherine O’Connor, Joanne F. Chou, Marinela Capanu, Wungki Park, Chaitanya Bandlamudi +19 more

Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial

Research Square(2025)10.21203/rs.3.rs-7334701/v1
N/A
0.214DataRank · unranked
3 citations

Catherine O’Connor, Joanne F. Chou, Marc Hilmi, Zeynep Tarcan, Carly Schwartz +61 more

Association between remote monitoring and acute care visits in high-risk patients initiating intravenous antineoplastic therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1578
N/A
0.115DataRank · unranked
1 citations

Kevin Nicholas, Jessica Flynn, Katherine S. Panageas, Nicholas Silva, Elaine Duck +13 more

Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma

Cancer(2025)10.1002/cncr.70088
Top 78%
0.104DataRank
Top 78%1 citations

Emily Manin, Joanne Chou, Robert J. Torphy, Caitlin A. McIntyre, Vinod P. Balachandran +11 more

Clinical relevance of clonal hematopoiesis in metastatic gastrointestinal malignancies.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16082
N/A
0.104DataRank · unranked
1 citations

Ryan Ptashkin, Andrea Cercek, Rona Yaeger, Kelly L. Bolton, Sree B. Chalasani +12 more

Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf139
N/A
0DataRank · unranked
4 citations

Lily V. Saadat, Catherine O’Connor, Joanne F. Chou, Anita S. Bowman, Fei Xu +18 more